41 results
DEFM14A
ORTX
Orchard Therapeutics plc
16 Nov 23
Proxy related to merger
4:45pm
of the transaction were completed, and with the oversight of the Compensation Committee. After discussion, the members of the Compensation Committee approved … economic conditions, availability of third-party reimbursement, increases in regulatory oversight, competition, pricing, reimbursement, research
PREM14A
ORTX
Orchard Therapeutics plc
3 Nov 23
Preliminary proxy related to merger
5:11pm
economic terms of the transaction were completed, and with the oversight of the Compensation Committee. After discussion, the members of the Compensation … , the effect of global economic conditions, availability of third-party reimbursement, increases in regulatory oversight, competition, pricing, reimbursement
DEFA14A
ORTX
Orchard Therapeutics plc
5 Oct 23
Additional proxy soliciting materials
9:07am
in Auditing Standard No. 5 of the Public Company Accounting Oversight Board, as in effect on the date of this Agreement) in the design or operation
8-K
EX-2.1
ORTX
Orchard Therapeutics plc
5 Oct 23
Kyowa Kirin to Acquire Orchard Therapeutics
9:05am
of the Public Company Accounting Oversight Board, as in effect on the date of this Agreement) in the design or operation of internal control over financial
8-K
EX-1.1
qv2mi9
6 Oct 22
Entry into a Material Definitive Agreement
4:34pm